First, A Quick Refresher on BPC-157 Before we dive into injection sites, it's crucial to understand why BPC-157 is even in this conversation
GHK-Cu
The result, in theory, is a more favorable shift in the ratio of fat to muscle than either compound could achieve alone

Standard reconstitution (10mg/ml) Most common protocol: 50mg GHK-Cu powder Add 5ml bacteriostatic water Creates 10mg/ml concentration Easy math for dosing How to calculate doses: 1mg dose = 0.1ml (10 units on insulin syringe) 2mg dose = 0.2ml (20 units) 3mg dose = 0.3ml (30 units) Total doses: 25 doses at 2mg each Why this concentration works: Simple calculations Easy to measure Standard for anti-aging protocols Fits insulin syringe well Alternative reconstitution (5mg/ml) More dilute option: 50mg GHK-Cu powder Add 10ml bacteriostatic water Creates 5mg/ml concentration Dose calculations: 1mg dose = 0.2ml (20 units) 2mg dose = 0.4ml (40 units) 3mg dose = 0.6ml (60 units) Total doses: 25 doses at 2mg each Why use 5mg/ml: Larger injection volume (some prefer) Easier to measure precisely Less concentrated (gentler on tissue) Good for beginners High concentration option (20mg/ml) Concentrated protocol: 50mg GHK-Cu powder Add 2.5ml bacteriostatic water Creates 20mg/ml concentration Dose calculations: 2mg dose = 0.1ml (10 units) 3mg dose = 0.15ml (15 units) 4mg dose = 0.2ml (20 units) When to use: Want smaller injection volume Using higher doses (3-5mg) Experienced users Prefer concentrated solutions Recommendation: Start with 10mg/ml (50mg + 5ml water) - simplest and most versatile

We also supply quality tested products to customers around the world who count on our expertise to avail various medicines like Rifaximin Tablets, Novomix 30 Flexpen Biphasic Insulin Aspart, Oxaliplatin IP Injection, etc
Collectively, these findings suggest that nose-to-brain delivery of L-penetratin/insulin was effective in the early stage of cognitive dysfunction and that nasal administration of L-penetratin/exendin-4 with insulin boosted therapeutic effect of exendin-4 in the progressive memory dysfunction in vivo